(0.40%) 5 120.25 points
(0.37%) 38 382 points
(0.51%) 16 010 points
(-1.41%) $82.67
(4.84%) $2.02
(0.42%) $2 357.00
(0.42%) $27.65
(4.61%) $964.65
(-0.26%) $0.932
(-0.41%) $10.98
(-0.59%) $0.796
(1.69%) $93.42
-0.42% HKD 4.77
Live Chart Being Loaded With Signals
SSY Group Limited, an investment holding company, researches, develops, manufactures, and sells various pharmaceutical products to hospitals and distributors in the People's Republic of China and internationally...
Stats | |
---|---|
Tagesvolumen | 2.42M |
Durchschnittsvolumen | 2.05M |
Marktkapitalisierung | 14.16B |
EPS | HKD0 ( 2024-03-27 ) |
Last Dividend | HKD0.0700 ( 2023-09-14 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 10.84 |
ATR14 | HKD0.00700 (0.15%) |
Volumen Korrelation
SSY Group Ltd Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
SSY Group Ltd Korrelation - Währung/Rohstoff
SSY Group Ltd Finanzdaten
Annual | 2023 |
Umsatz: | HKD6.46B |
Bruttogewinn: | HKD3.49B (53.99 %) |
EPS: | HKD0.440 |
FY | 2023 |
Umsatz: | HKD6.46B |
Bruttogewinn: | HKD3.49B (53.99 %) |
EPS: | HKD0.440 |
FY | 2022 |
Umsatz: | HKD6.43B |
Bruttogewinn: | HKD3.44B (53.46 %) |
EPS: | HKD0.380 |
FY | 2021 |
Umsatz: | HKD5.36B |
Bruttogewinn: | HKD3.17B (59.18 %) |
EPS: | HKD0.260 |
Financial Reports:
No articles found.
SSY Group Ltd Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0.0600 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.160 (N/A) |
HKD0.0700 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.00500 | 2008-05-23 |
Last Dividend | HKD0.0700 | 2023-09-14 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 32 | -- |
Total Paid Out | HKD1.257 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 4.32 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 7.77 | |
Div. Directional Score | 10.00 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
6117.HK | Ex Dividend Junior | 2023-05-22 | Sporadic | 0 | 0.00% | |
1857.HK | Ex Dividend Junior | 2023-08-23 | Semi-Annually | 0 | 0.00% | |
0881.HK | Ex Dividend Junior | 2023-06-23 | Annually | 0 | 0.00% | |
0026.HK | Ex Dividend Junior | 2023-10-03 | Semi-Annually | 0 | 0.00% | |
2669.HK | Ex Dividend Knight | 2023-06-23 | Semi-Annually | 0 | 0.00% | |
1428.HK | Ex Dividend Knight | 2023-08-23 | Annually | 0 | 0.00% | |
0518.HK | Ex Dividend Junior | 2023-09-01 | Sporadic | 0 | 0.00% | |
6869.HK | Ex Dividend Junior | 2023-07-04 | Annually | 0 | 0.00% | |
1977.HK | Ex Dividend Knight | 2023-09-11 | Semi-Annually | 0 | 0.00% | |
1036.HK | Ex Dividend Junior | 2023-06-21 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.204 | 1.500 | 5.92 | 8.88 | [0 - 0.5] |
returnOnAssetsTTM | 0.110 | 1.200 | 6.33 | 7.59 | [0 - 0.3] |
returnOnEquityTTM | 0.199 | 1.500 | 8.91 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.338 | -1.000 | 6.62 | -6.62 | [0 - 1] |
currentRatioTTM | 2.03 | 0.800 | 4.84 | 3.87 | [1 - 3] |
quickRatioTTM | 1.587 | 0.800 | 5.37 | 4.30 | [0.8 - 2.5] |
cashRatioTTM | 0.659 | 1.500 | 7.45 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.282 | -1.500 | 5.31 | -7.96 | [0 - 0.6] |
interestCoverageTTM | 11.88 | 1.000 | 6.71 | 6.71 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.325 | 2.00 | 9.89 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.0880 | 2.00 | 9.96 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.486 | -1.500 | 8.06 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.540 | 1.000 | 4.34 | 4.34 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.231 | 1.000 | 7.39 | 7.39 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.287 | 1.000 | 9.52 | 9.52 | [0.2 - 2] |
assetTurnoverTTM | 0.540 | 0.800 | 9.73 | 7.79 | [0.5 - 2] |
Total Score | 12.25 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 10.78 | 1.000 | 9.01 | 0 | [1 - 100] |
returnOnEquityTTM | 0.199 | 2.50 | 9.30 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.0880 | 2.00 | 9.97 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 4.81 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.325 | 2.00 | 9.89 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.338 | 1.500 | 6.62 | -6.62 | [0 - 1] |
pegRatioTTM | 0.559 | 1.500 | 9.61 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.149 | 1.000 | 8.76 | 0 | [0.1 - 0.5] |
Total Score | 7.77 |
SSY Group Ltd
SSY Group Limited, an investment holding company, researches, develops, manufactures, and sells various pharmaceutical products to hospitals and distributors in the People's Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC soft bags, upright soft bags, PP plastic bottles, and glass bottle infusion solutions, as well as ampoule injections. It also provides small volume injections, oral preparations, Chinese medicine preparations, and biological preparations, as well as bulk pharmaceutical products and medical materials. In addition, the company is involved in the research, development, and consulting of pharmaceutical technology; provision of logistics services for pharmaceutical products; and food, beverages, and catering business. It sells its products under Shimen brand name. The company was formerly known as Lijun International Pharmaceutical (Holding) Co., Ltd. and changed its name to SSY Group Limited in May 2015. The company was incorporated in 2004 and is headquartered in Wanchai, Hong Kong. SSY Group Limited is a subsidiary of China Pharmaceutical Co., Ltd.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.